NATCO Pharma Ltd.
NSE: NATCOPHARM BSE: 524816 ISIN: INE987B01026 Healthcare
No upcoming corporate action announced. Last: Rights issue (2 for every 21 held at ₹750), ex-date 1 Oct 2026, record date 1 Oct 2026.
How much will I receive?
Interim dividend of ₹1.50 per share, ex-date 20 Aug 2026.
Dividend before tax
₹150
Tax is deducted according to your own situation.
Ex-date and record date
The record date is when the company checks who its shareholders are. The ex-date is the first day the shares trade without the benefit.
With India's T+1 settlement the two usually fall on the same day, so you need to have bought the shares before the ex-date.
Corporate actions
| Event | Details | Ex-date | Record date | Source |
|---|---|---|---|---|
| Rights issue | 2 for every 21 held at ₹750 | 1 Oct 2026 | 1 Oct 2026 | Filing |
| Interim dividend | ₹1.50 per share | 20 Aug 2026 | 20 Aug 2026 | Filing |
| Interim dividend | ₹1.50 per share | 18 Feb 2026 | 18 Feb 2026 | Filing |
| Interim dividend | ₹1.50 per share | 20 Nov 2025 | 20 Nov 2025 | Filing |
| Interim dividend | ₹2 per share | 19 Aug 2025 | 19 Aug 2025 | Filing |
| Interim dividend | ₹1.50 per share | 18 Feb 2025 | 18 Feb 2025 | Filing |
| Interim dividend | ₹1.50 per share | 27 Nov 2024 | 27 Nov 2024 | Filing |
| Interim dividend | ₹3 per share | 23 Aug 2024 | 23 Aug 2024 | Filing |
| Interim dividend | ₹1.25 per share | 26 Feb 2024 | 26 Feb 2024 | Filing |
Data last checked 10 Nov 2026. Spotted a wrong date? Report it.